Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology

Data-Related Challenges in Cost-Effectiveness Analyses of Vaccines

(2022) Jamison Pike et al.   Applied Health Economics and Health Policy

Post-HPV-Vaccination Mast Cell Activation Syndrome: Possible Vaccine-Triggered Escalation of Undiagnosed Pre-Existing Mast Cell Disease?

(2022) Lawrence B. Afrin et al.   Vaccines

Human Papillomavirus Distribution in Women with Abnormal Pap Smear and/or Cervical Intraepithelial Neoplasia in Vaccination Era. A Single-Center Study in the North Italian Population

(2021) Barbara Gardella et al.   Microorganisms

Infections in temporal proximity to HPV vaccination and adverse effects following vaccination in Denmark: A nationwide register-based cohort study and case-crossover analysis

(2021) Lene Wulff Krogsgaard et al.   PLOS MEDICINE

Genotype Distribution Change After Human Papillomavirus Vaccination in Two Autonomous Communities in Spain

(2021) Javier Freire-Salinas et al.   Frontiers in Cellular and Infection Microbiology

Incidence and Types of Human Papillomavirus Infections in Adolescent Girls and Young Women Immunized With the Human Papillomavirus Vaccine

(2021) Nicolas F. Schlecht et al.   JAMA Network Open

The efficacy of human papillomavirus vaccination in young Japanese girls: the interim results of the OCEAN study

(2021) Kosuke Hiramatsu et al.   Human Vaccines & Immunotherapeutics

Human Papillomavirus Genotype Replacement: Still Too Early to Tell?

(2020) Irene Man et al.   JOURNAL OF INFECTIOUS DISEASES

Assessing Impact of HPV Vaccination on Cervical Cancer Incidence in Women 15-29 years in the United States, 1999-2017: An Ecologic Study

(2020) Jacqueline M Mix et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Human papilloma virus (HPV) prevalence upon HPV vaccination in Swedish youth: a review based on our findings 2008–2018, and perspectives on cancer prevention

(2020) Juan Du et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Risk Factors for Non–Human Papillomavirus (HPV) Type 16/18 Cervical Infections and Associated Lesions Among HPV DNA–Negative Women Vaccinated Against HPV-16/18 in the Costa Rica Vaccine Trial

(2020) Mónica S Sierra et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial

(2020) Carolina Porras et al.   LANCET ONCOLOGY

Potential Effects of Human Papillomavirus Type Substitution, Superinfection Exclusion and Latency on the Efficacy of the Current L1 Prophylactic Vaccines

(2020) Ian N. Hampson et al.   Viruses-Basel

Trends in High-grade Cervical Lesions and Cervical Cancer Screening in 5 States, 2008–2015

(2018) Julia Warner Gargano et al.   CLINICAL INFECTIOUS DISEASES